Research articleProduction of bioactive Ginsenoside Rg3 (cas 11019-45-7)(S) and compound K using recombinant Lactococcus lactis
-
Add time:08/21/2019 Source:sciencedirect.com
BackgroundGinsenoside Rg3(S) and compound K (C-K) are pharmacologically active components of ginseng that promote human health and improve quality of life. The aim of this study was to produce Rg3(S) and C-K from ginseng extract using recombinant Lactococcus lactis.
We also recommend Trading Suppliers and Manufacturers of Ginsenoside Rg3 (cas 11019-45-7). Pls Click Website Link as below: cas 11019-45-7 suppliers
Prev:Whey protein stabilized nanoemulsion: A potential delivery system for Ginsenoside Rg3 (cas 11019-45-7) whey protein stabilized nanoemulsion: Potential Rg3 delivery system
Next:Effects of Ginsenoside Rg3 (cas 11019-45-7) on fatigue resistance and SIRT1 in aged rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleGinsenoside Rg3 (cas 11019-45-7) suppresses mast cell–mediated allergic inflammation via mitogen-activated protein kinase signaling pathway08/25/2019
- Molecular and cellular pharmacology20(S)-Ginsenoside Rg3 (cas 11019-45-7) sensitizes human non-small cell lung cancer cells to icotinib through inhibition of autophagy08/24/2019
- Full length articleGinsenoside Rg3 (cas 11019-45-7) inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-22108/23/2019
- Effects of Ginsenoside Rg3 (cas 11019-45-7) on fatigue resistance and SIRT1 in aged rats08/22/2019
- Whey protein stabilized nanoemulsion: A potential delivery system for Ginsenoside Rg3 (cas 11019-45-7) whey protein stabilized nanoemulsion: Potential Rg3 delivery system08/20/2019
- Ginsenoside Rg3 (cas 11019-45-7) inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT108/19/2019
- Ginsenoside Rg3 (cas 11019-45-7), a component of ginseng, induces pro-thrombotic activity of erythrocytes via hemolysis-associated phosphatidylserine exposure08/18/2019
- Ginsenoside Rg3 (cas 11019-45-7) upregulates myotube formation and mitochondrial function, thereby protecting myotube atrophy induced by tumor necrosis factor-alpha08/17/2019
- Ginsenoside Rg3 (cas 11019-45-7) improves cyclophosphamide-induced immunocompetence in Balb/c mice08/16/2019
-
Health and Chemical more >